Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOSAIC: Decitabine and Tetrahydrouridine in Clonal Cytopenia of Uncertain Significance
NCT07435636Phase 2Not yet recruiting
- Sponsor
- Clinical Hub for Interventional Research
- Start
- Dec 2026
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine, tetrahydrouridine in clonal cytopenia of undetermined significance (CCUS), sponsored by Clinical Hub for Interventional Research. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
decitabinetetrahydrouridine
03
Conditions
clonal cytopenia of undetermined significance (CCUS)
Beyond the preview
Go deeper on NCT07435636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07435636.